Berkeley Lights (NASDAQ:BLI) and Harvard Bioscience (NASDAQ:HBIO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
This table compares Berkeley Lights and Harvard Bioscience’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and target prices for Berkeley Lights and Harvard Bioscience, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Berkeley Lights currently has a consensus target price of $95.00, indicating a potential upside of 94.47%. Harvard Bioscience has a consensus target price of $9.00, indicating a potential upside of 38.25%. Given Berkeley Lights’ higher possible upside, equities research analysts plainly believe Berkeley Lights is more favorable than Harvard Bioscience.
Institutional & Insider Ownership
27.0% of Berkeley Lights shares are held by institutional investors. Comparatively, 64.9% of Harvard Bioscience shares are held by institutional investors. 5.4% of Harvard Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Berkeley Lights and Harvard Bioscience’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Harvard Bioscience||$116.18 million||2.24||-$4.69 million||$0.12||54.25|
Berkeley Lights has higher earnings, but lower revenue than Harvard Bioscience.
Harvard Bioscience beats Berkeley Lights on 6 of the 9 factors compared between the two stocks.
About Berkeley Lights
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.
About Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Receive News & Ratings for Berkeley Lights Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Berkeley Lights and related companies with MarketBeat.com's FREE daily email newsletter.